Update On Overall Survival In Columbus: A Randomized Phase Iii Trial Of Encorafenib (Enco) Plus Binimetinib (Bini) Versus Vemurafenib (Vem) Or Enco In Patients With Braf V600-Mutant Melanoma.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要